Overview


According to FutureWise analysis, the market for Animal Health in 2023 is US$ 158.01 billion, and is expected to reach US$ 232.03 billion by 2031 at a CAGR of 4.90%.

Animal healthcare is a comprehensive field encompassing a range of medical services and practices designed to encourage and maintain the health and well-being of animals, both domestic and wild. Like human healthcare, animal healthcare involves preventive measures such as vaccinations, parasite control, dental care, and nutrition management to prevent illnesses. When animals fall ill or sustain injuries, they receive medical treatment, including surgeries, diagnostic services, and emergency care. Rehabilitation, behavioral support, and mental health considerations are integral to ensuring animals' overall wellness.

The Department of Animal Health has a structured work plan for active case management. Each animal within the hospital is inspected at least twice daily by the veterinary hospital keeper and at least once daily by a veterinarian. Daily rounds are held with the entire hospital staff and often a member of the Pathology Department. During rounds, each animal being acutely managed by the hospital is discussed, procedures planned for that day, and scheduling for future procedures. In addition to daily rounds, the veterinary staff maintains an active case log of both acute cases and chronic cases. This log is updated daily by all veterinarians in clinical service. The veterinary staff meets twice weekly to discuss the management of all cases in the log.

FutureWise Market Research has published a report that provides an insightful analysis animal healthcare market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, animal healthcare market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dechra Pharmaceuticals
  • Elanco
  • Merck And Co,Inc
  • Zoetis
  • B Braun Melsungen AG
  • Medtronic
  • Idexx Laboratories

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Animal Health Market:

  • In May 2022- The assets of Victorian Equine Group (VEG) and Romesey Veterinary Surgery are being acquired by Apiam Animal Health, a consortium of veterinary practices in Australia, for a combined sum of A$13.75 million (equivalent to US$9.89 million). The transaction will be divided into A$9.8 million in cash and A$4.0 million in stakes.

  • In May 2022- The DNA TRACEBACK Fisheries platform was introduced by MSD Animal Health, a subsidiary of Merck & Co., Inc. This novel DNA-based analytical tool assists governmental bodies and fishery agencies in assessing the sustainable harvest capacity of natural fish populations and establishing the maximum permissible catch for fishermen operating within their geographic area.

The increasing incidence of zoonotic diseases, which may transmit between animals and humans, is likely to dominate the growth of the animal healthcare market during the forecast period. Increased public awareness of the interrelation between animal and human health fosters greater demand for disease prevention, diagnostics, and treatment options, thus spurring investments and advancements in animal healthcare to effectively combat and manage zoonotic threats, eventually contributing to the expansion of the market. For instance, the World Health Organization notes that around 60% of newly identified infectious diseases globally are zoonotic. Over three decades, 30 human pathogens have emerged, 75% from animals. Rising zoonoses pose increasing public health risks in the WHO's Eastern Mediterranean Region. Additionally, 18 of 22 nations reported swift outbreaks and high mortality rates from emerging zoonotic diseases in the last two decades. These elements are expected to drive global animal healthcare industry growth. Therefore, these above-mentioned factors are poised to propel the growth of the global animal healthcare industry. Moreover, the growing trend of pet ownership, especially within urban areas, is boosting demand for the animal healthcare market. This surge in pet companionship, driven by factors like increased disposable income, changing lifestyles, and a heightened emphasis on companionship and emotional well-being, is significantly amplifying the demand for a diverse range of animal healthcare products and services. As more individuals embrace pets as integral members of their families, the need for comprehensive veterinary care, preventive treatments, diagnostics, and specialized services is experiencing substantial growth. Furthermore, strict regulations and approval processes governing animal healthcare products and services are hindering the growth of the animal healthcare market. While these regulations are essential for ensuring, these rules may unintentionally impede innovation and market access. Stringent testing, documentation, and compliance demands create time and resource challenges, deterring smaller businesses and novel solutions from entering.

By Product Type

  • Pharmaceuticals
    • Drugs
      • Antiparasitic
      • Anti-inflammatory
      • Anti-infectives
      • Others
    • Vaccines
      • Modified Live Vaccines (MLV)
      • Killed Inactivated Vaccines
      • Others
    • Medicated Feed Additives
      • Antibiotics
      • Vitamins
      • Amino acids
      • Enzymes
      • Antioxidants
      • Prebiotics and probiotics
      • Minerals
      • Others
  • Medical Devices
    • Veterinary Diagnostic Equipment
    • Veterinary Anesthesia Equipment
    • Veterinary Patient Monitoring Equipment
    • Veterinary Surgical Equipment
    • Veterinary Consumables
    • Others
  • Veterinary Services

By Animal Type

  • Livestock Animals
    • Poultry
    • Swine
    • Cattle
    • Fish
    • Others
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Others

By Distribution Channel

  • Pharmacies
  • Online
  • Distributors

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Afric

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is attributed to a range of substantial initiatives taken by government animal welfare organizations, aiming to enhance animal health continually. Additionally, the increasing consumption of animal products is driving rising demand for feed additives. The United States, as the world's largest beef producer and second-largest beef exporter, plays a significant role in this demand surge. Moreover, advancements in animal diagnostics technology, the growing incidence of zoonotic diseases, and heightened awareness among pet owners are all projected to contribute to the expansion of the market. Collaborative measures among major players to bolster their research and development capabilities and uphold stringent quality standards are expected further to fuel demand across this region throughout the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Animal Healthcare Market By Product Type, By Animal Type, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Animal Healthcare Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Healthcare Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Animal Healthcare Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Animal Healthcare Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceuticals
         1.1. Drugs
          1.1.1. Antiparasitic
          1.1.2. Anti-inflammatory
          1.1.3. Anti-infectives
          1.1.4. Others
         1.2. Vaccines
          1.2.1. Modified Live Vaccines (MLV)
          1.2.2. Killed Inactivated Vaccines
          1.2.3. Others
         1.3. Medicated Feed Additives
          1.3.1. Antibiotics
          1.3.2. Vitamins
          1.3.3. Amino acids
          1.3.4. Enzymes
          1.3.5. Antioxidants
          1.3.6. Prebiotics and probiotics
          1.3.7. Minerals
          1.3.8. Others
        2. Medical Devices
         2.1. Veterinary Diagnostic Equipment
         2.2. Veterinary Anesthesia Equipment
         2.3. Veterinary Patient Monitoring Equipment
         2.4. Veterinary Surgical Equipment
         2.5. Veterinary Consumables
         2.6. Others
        3. Veterinary Services

  • 8.   Animal Healthcare Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Livestock Animals
         1.1. Poultry
         1.2. Swine
         1.3. Cattle
         1.4. Fish
         1.5. Others
        2. Companion Animals
         2.1. Dogs
         2.2. Cats
         2.3. Horses
         2.4. Others

  • 9.   Animal Healthcare Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmacies
        2. Online
        3. Distributors

  • 10.   North America Animal Healthcare Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Animal Healthcare Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Animal Healthcare Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Animal Healthcare Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Bayer AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boehringer Ingelheim International GmbH
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Dechra Pharmaceuticals
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Elanco
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Merck and Co,Inc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Zoetis
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. B Braun Melsungen AG
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Medtronic
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Idexx Laboratories
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by Cerner Corporationinistrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients